PharmaShots | Incisive News in 3 Shots

Subscribe Now

lung cancer

Novartis Reports Results of Canakinumab in P-III CANOPY-1 Study for the Treatment of Lung Cancer

Novartis Reports Results of Canakinumab in P-III CANOPY-1 Study for the Treatment of Lung Cancer

October 25, 2021

Sanofi Signs a Non-Exclusive Clinical Collaboration Agreement with Mirati to Evaluate Adagrasib + SAR442720 (RMC-4630) in P-I/II Study for KRAS G12C-Mutated Lung Cancer

Sanofi Signs a Non-Exclusive Clinical Collaboration Agreement with Mirati to Evaluate Adagrasib + SAR442720 (RMC-4630) in P-I/II S...

October 8, 2021

AstraZeneca and Hutchmed Initiate P-III SANOVO Trial for Orpathys (savolitinib) + Tagrisso (osimertinib) as a 1L Therapy for Non-small Cell Lung Cancer in China

AstraZeneca and Hutchmed Initiate P-III SANOVO Trial for Orpathys (savolitinib) + Tagrisso (osimertinib) as a 1L Therapy for Non-s...

September 9, 2021

PharmaShots Interview: Q BioMed's Denis Corin Shares Insights on the Agreement to Serve US Department of Defense and Veterans Affairs

PharmaShots Interview: Q BioMed's Denis Corin Shares Insights on the Agreement to Serve US Department of Defense and Veterans Affa...

July 13, 2021

Boehringer Ingelheim and MD Anderson Expand their Collaboration to Accelerate Targeted Therapies for Lung Cancer

Boehringer Ingelheim and MD Anderson Expand their Collaboration to Accelerate Targeted Therapies for Lung Cancer

April 15, 2021

Roche Reports Results of Tecentriq in P-III IMpower010 Study for Patients with Early Lung Cancer

Roche Reports Results of Tecentriq in P-III IMpower010 Study for Patients with Early Lung Cancer

March 23, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us